Allan James
Imperial College Healthcare NHS Trust(GB)NHS Greater Glasgow and Clyde(GB)
Publications by Year
Research Areas
Head and Neck Cancer Studies, Glioma Diagnosis and Treatment, Cancer Diagnosis and Treatment, Head and Neck Surgical Oncology, Radiomics and Machine Learning in Medical Imaging
Most-Cited Works
- → A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma(2016)161 cited
- → PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status(2017)63 cited
- → Health economic evaluation of a serum-based blood test for brain tumour diagnosis: exploration of two clinical scenarios(2018)54 cited
- → 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers(2019)47 cited
- → Phase I clinical trials evaluating olaparib in combination with radiotherapy (RT) and/or temozolomide (TMZ) in glioblastoma patients: Results of OPARATIC and PARADIGM phase I and early results of PARADIGM-2.(2018)35 cited
- → The influence of MRI scan position on patients with oropharyngeal cancer undergoing radical radiotherapy(2013)28 cited
- → Analysis of dose using CBCT and synthetic CT during head and neck radiotherapy: A single centre feasibility study(2020)24 cited
- → Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial(2024)22 cited
- → Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial(2021)20 cited
- → Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck(2019)13 cited